Bractoppin is a potent and selective inhibitor of phosphopeptide recognition by the BRCA1 tBRCT domain, which selectively interrupts BRCA1 tBRCT-dependent signals evoked by DNA damage.
Physicochemical Properties
Molecular Formula | C25H23FN4O |
Molecular Weight | 414.4747 |
Exact Mass | 414.19 |
Elemental Analysis | C, 72.45; H, 5.59; F, 4.58; N, 13.52; O, 3.86 |
CAS # | 2290527-07-8 |
PubChem CID | 137519541 |
Appearance | White to off-white solid powder |
Density | 1.299±0.06 g/cm3 |
Boiling Point | 625.7±65.0 °C |
LogP | 4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Heavy Atom Count | 31 |
Complexity | 604 |
Defined Atom Stereocenter Count | 0 |
SMILES | FC1=C([H])C([H])=C([H])C([H])=C1C([H])([H])N1C([H])([H])C([H])([H])N(C(C2C([H])=C([H])C3=C(C=2[H])N([H])C(C2C([H])=C([H])C([H])=C([H])C=2[H])=N3)=O)C([H])([H])C1([H])[H] |
InChi Key | UHDGSNOZRAAGIZ-UHFFFAOYSA-N |
InChi Code | InChI=1S/C25H23FN4O/c26-21-9-5-4-8-20(21)17-29-12-14-30(15-13-29)25(31)19-10-11-22-23(16-19)28-24(27-22)18-6-2-1-3-7-18/h1-11,16H,12-15,17H2,(H,27,28) |
Chemical Name | [4-[(2-fluorophenyl)methyl]piperazin-1-yl]-(2-phenyl-3H-benzimidazol-5-yl)methanone |
Synonyms | Bractoppin |
HS Tariff Code | 2934.99.03.00 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
ln Vitro | Bractoppin showed nanomolar effectiveness in the MST experiment, with a binding IC50 value of 74 nM, in distancing the homologous BACH1 phosphopeptide substrate of BRCA1 tBRCT [1]. ECT2, TOPBP1 1/2, TOBP1 7/8, and Bractoppin (0-100 μM) did not bind to fluorescently tagged tBRCT domains in the antagonistic profile of the competitive MST assay[1]. Whereas bractoppin (100 μM) has minimal influence on the accumulation of irradiation MDC1 at sites of DNA damage, it interferes locally with the development of irradiated BRCA1-containing foci. Similarly, on irradiated TOPBP1 (a numerous physically similar tBRCT), bractoppin prevents G2 arrest generated by 4 Gy radiation in a dose-dependent manner. Recruitment is not significantly affected by bractoppin (10–100 μM; 0.5 h prior to irradiation (32)) or domain-specific proteins (10 μM, 30 μM) [1]. The percentages of cells arrested in the G2 phase were 64%, 42%, and 25% at 100 μM, respectively[1]. |
References |
[1]. Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling. Cell Chem Biol. 2018 Jun 21;25(6):677-690.e12. |
Solubility Data
Solubility (In Vitro) |
DMSO: 83~250 mg/mL (200.3~603.2 mM) Ethanol: ~83 mg/mL |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.02 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (5.02 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (5.02 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.4127 mL | 12.0636 mL | 24.1272 mL | |
5 mM | 0.4825 mL | 2.4127 mL | 4.8254 mL | |
10 mM | 0.2413 mL | 1.2064 mL | 2.4127 mL |